Metraipolis › archive › dc_cd779f8e765b

Next-Generation Nanocarrier Platforms for RNA Vaccines: Advances in Formulation, Stability Engineering, and Translational Manufacturing Challenges — Europe PMC PMID:42654026

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42654026
DOI
10.3390/pharmaceutics18080909
License (as archived)
solo-consultazione
Archived
2026-10-17T22:06:31.582Z
SHA-256 of the archived text
056316a9b67f1905b726d882e83f3929918cb02604968edaf6d726a0e3701fec
Stable URL of this page
https://metraipolis.com/documento/dc_cd779f8e765b

How to cite

Next-Generation Nanocarrier Platforms for RNA Vaccines: Advances in Formulation, Stability Engineering, and Translational Manufacturing Challenges — Europe PMC PMID:42654026 — Europe PMC (en), https://europepmc.org/article/MED/42654026 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd779f8e765b (Metraipolis archive dc_cd779f8e765b, sha256 056316a9b67f1905b726d882e83f3929918cb02604968edaf6d726a0e3701fec)
BibTeX
@misc{dccd779f8e765b,
  title = {Next-Generation Nanocarrier Platforms for RNA Vaccines: Advances in Formulation, Stability Engineering, and Translational Manufacturing Challenges — Europe PMC PMID:42654026},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42654026},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd779f8e765b; sha256 056316a9b67f1905b726d882e83f3929918cb02604968edaf6d726a0e3701fec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42654026. Agents can read the archived copy with the MCP tool read_document.